BR0312821A - 4-(4-metil-piperazin-1-il-metil)-n-[(4-metil-3-(4-piridin-3-i l)-pirimidin-2-il-amino)-fenil]-benzamida para tratar câncer anaplásico da tireóide - Google Patents

4-(4-metil-piperazin-1-il-metil)-n-[(4-metil-3-(4-piridin-3-i l)-pirimidin-2-il-amino)-fenil]-benzamida para tratar câncer anaplásico da tireóide

Info

Publication number
BR0312821A
BR0312821A BR0312821-0A BR0312821A BR0312821A BR 0312821 A BR0312821 A BR 0312821A BR 0312821 A BR0312821 A BR 0312821A BR 0312821 A BR0312821 A BR 0312821A
Authority
BR
Brazil
Prior art keywords
methyl
piperazin
benzamide
pyrimidin
pyridin
Prior art date
Application number
BR0312821-0A
Other languages
English (en)
Inventor
Alexej Podtcheko
Satoshi Tsuda
Shumichi Yamashita
Akira Ohtsuru
Original Assignee
Akira Ohtsuru
Alexej Podtcheko
Satoshi Tsuda
Shumichi Yamashita
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akira Ohtsuru, Alexej Podtcheko, Satoshi Tsuda, Shumichi Yamashita, Novartis Ag filed Critical Akira Ohtsuru
Publication of BR0312821A publication Critical patent/BR0312821A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"4-(4-METIL-PIPERAZIN-1-IL-METIL)-N-[(4-METIL-3(4-PIRIDIN-3-I L)-PIRIMIDIN-2-IL-AMINO)-FENIL]-BENZAMIDA PARA TRATAR CâNCER ANAPLáSICO DA TIREóIDE". A invenção refere-se ao uso de 4-(4-metil-piperazin-1-il-metil)-N[(4-metil-3-(4-piridin-3-il)-pirimidin-2-il-a mino)-fenil]-benzamida da seguinte fórmula: ou um seu sal farmaceuticamente aceitável para a fabricação de um medicamento para o tratamento de cânceres anaplásicos da tireóide.
BR0312821-0A 2002-07-24 2003-05-23 4-(4-metil-piperazin-1-il-metil)-n-[(4-metil-3-(4-piridin-3-i l)-pirimidin-2-il-amino)-fenil]-benzamida para tratar câncer anaplásico da tireóide BR0312821A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39841002P 2002-07-24 2002-07-24
US45455703P 2003-03-14 2003-03-14
PCT/IB2003/001985 WO2004009088A1 (en) 2002-07-24 2003-05-23 4-(4-methylpiperazin-1-ylmethyl)-n-[4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating anaplastic thyroid cancer

Publications (1)

Publication Number Publication Date
BR0312821A true BR0312821A (pt) 2005-04-19

Family

ID=30773082

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0312821-0A BR0312821A (pt) 2002-07-24 2003-05-23 4-(4-metil-piperazin-1-il-metil)-n-[(4-metil-3-(4-piridin-3-i l)-pirimidin-2-il-amino)-fenil]-benzamida para tratar câncer anaplásico da tireóide

Country Status (8)

Country Link
US (1) US20060106026A1 (pt)
EP (1) EP1551408A1 (pt)
JP (1) JP2005533838A (pt)
CN (1) CN1671389A (pt)
AU (1) AU2003232376A1 (pt)
BR (1) BR0312821A (pt)
CA (1) CA2498982A1 (pt)
WO (1) WO2004009088A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115703760B (zh) * 2021-08-11 2024-05-31 山东大学 2,4-二取代嘧啶类细胞周期蛋白依赖性激酶酶抑制剂及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4141219A1 (de) * 1991-12-13 1993-06-17 Basf Ag Verfahren zur herstellung von tetrahydropyrancarbonsaeureestern
CO4940418A1 (es) * 1997-07-18 2000-07-24 Novartis Ag Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso
ITMI992711A1 (it) * 1999-12-27 2001-06-27 Novartis Ag Composti organici
CN1617755A (zh) * 2001-11-30 2005-05-18 先灵公司 法尼基蛋白转移酶抑制剂和其它抗肿瘤剂联合使用在制备抗癌症的药物中的应用

Also Published As

Publication number Publication date
WO2004009088A1 (en) 2004-01-29
CA2498982A1 (en) 2004-01-29
AU2003232376A1 (en) 2004-02-09
JP2005533838A (ja) 2005-11-10
EP1551408A1 (en) 2005-07-13
US20060106026A1 (en) 2006-05-18
CN1671389A (zh) 2005-09-21

Similar Documents

Publication Publication Date Title
BR0312873A (pt) 4-(4-metilpiperazin-1-ilmetil)-n-[4-metil-3-(4-piridin-3-il) pirimidin-2-ilamino)fenil] benzamida para tratamento de doenças associadas com ret cinase mutante
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
ATE408601T1 (de) Fredericamycin-derivate
PA8510801A1 (es) "tratamiento de la enfermedad neurodegenerativa"
BR0114870A (pt) Tratamento de tumores estromais gastrointestinais
BR0109703A (pt) Derivados de piperazina
BR0210075A (pt) Composto, composição farmacêutica, uso de um composto, e, métodos de tratamento ou profilaxia de doenças ou condições humanas, de distúrbios psicóticos ou distúrbios da debilitação intelectual e de fadiga de vÈo, cessamento de fumar, dependência de nicotina, dores, e para a colite ulcerativa
PT998473E (pt) Modificacao da forma de cristal de um derivado de n-fenil-2-pirimidinoamina processos para a sua preparacao e sua utilizacao
BR0316169A (pt) Derivados de indolil pirazinona úteis para tratamento de distúrbios e doenças hiperproliferativos associados com angiogênese
EA200500853A1 (ru) 2,4,6-тризамещённые пиримидины, являющиеся ингибиторами фосфотидилинозитол(pi)-3-киназы, и их применение при лечении рака
CO5261586A1 (es) Uso de pramipexol en el tratamiento de transtornos de adiccion
CY1110130T1 (el) Παραγωγα μορφολινης για χρηση ως αγωνιστες ντοπαμινης στην θεραπευτικη αγωγη σεξουαλικης δυσλειτουργιας i.α.
BR0316458A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
CY1110061T1 (el) Συνθεσεις περιλαμβανοντας ενωσεις μοδαφινιλης
BR0207316A (pt) Derivados de epotilona para o tratamento de tumores refratários
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
BR0107628A (pt) l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial
BRPI0408689A (pt) derivados de benzenosulfonamida, método para preparação e utilização disso para o tratamento da dor
BR0017120A (pt) Composição farmacêutica
SE0101082D0 (sv) Novel use
EA200701181A1 (ru) Лекарственные средства, предназначенные для лечения или предупреждения фиброзных заболеваний
MY137595A (en) N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide for the treatment of cancer
ATE289204T1 (de) Arzneimittel zur vorbeugung / behandlung / inhibierung des fortschritts für einfache oder preproliferative retinopathie
BR0312821A (pt) 4-(4-metil-piperazin-1-il-metil)-n-[(4-metil-3-(4-piridin-3-i l)-pirimidin-2-il-amino)-fenil]-benzamida para tratar câncer anaplásico da tireóide
CR9074A (es) Agente para la profilaxis o tratamiento del sindrome metabolico

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2157 DE 08/05/2012.